Mode
Text Size
Log in / Sign up

Vitamin K2 supplementation shows mixed neuromuscular effects in healthy older adults

Vitamin K2 supplementation shows mixed neuromuscular effects in healthy older adults
Photo by Yvette S / Unsplash
Key Takeaway
Consider isolated neuromuscular efficiency signals from vitamin K2 in older adults as preliminary and requiring confirmation.

This 12-week randomized controlled trial enrolled 71 healthy participants (35 aged 18-40 years, 36 aged 65+ years) to assess vitamin K2 (menaquinone-7, MK-7, 240 μg/d) versus placebo (cellulose). The primary outcome was not reported; secondary outcomes included knee extensor torque, functional ability, muscle soreness, systemic markers of muscle damage and inflammation, electromechanical delay (EMD), and electromyography root mean square (RMS).

Circulating MK-7 levels increased significantly with supplementation (P < 0.001). However, vitamin K2 had no effect on muscle strength, physical function, muscle soreness, or inflammatory responses. In older adults specifically, the vitamin K2 group showed lower EMD at all time points (P = 0.03) and higher RMS postexercise (P = 0.01). At 72 hours postexercise, creatine kinase (CK) levels were lower in older adults receiving vitamin K2 (P = 0.02).

Safety and tolerability data were not reported. A key limitation noted was the absence of a clear pattern in interleukin-6 (IL-6) or CK responses overall. The study population was small and healthy, limiting generalizability to clinical populations with muscle impairment. The clinical relevance of the isolated neuromuscular efficiency signals in older adults remains uncertain and requires confirmation in larger trials with clinically meaningful functional endpoints.

Study Details

Study typeRct
EvidenceLevel 2
PublishedApr 2026
View Original Abstract ↓
PURPOSE: Vitamin K2 supplementation has emerged as a strategy to enhance recovery and modulate postexercise physiological responses. This study aimed to assess the effects of vitamin K2 on recovery from muscle-damaging exercise in young and older adults. METHODS: Healthy young (18-40 yr) and older (65+ yr) adults were randomly assigned to either vitamin K2 (menaquinone-7, MK-7, 240 μg/d) or placebo (cellulose) for 12 wk in this double-blind randomized controlled trial. Before and after supplementation, knee extensor maximal torque, functional ability, muscle soreness, and systemic blood markers of muscle damage and inflammation were measured before (0 h) and 3, 24, 48, and 72-h postexercise. Data were analyzed using regression and mixed models. RESULTS: Seventy-one participants (35 young and 36 older) completed the study, with 12 wk of vitamin K2 supplementation increasing circulating MK-7 levels (P-value <0.001). There were no supplement × time effects for any variables. Significant supplement × time × older age interaction effects were noted for electromechanical delay (EMD) (P-value = 0.03), electromyography root mean square (RMS) (P-value = 0.01), interleukin-6 (IL-6) concentrations (P-value <0.001), and creatine kinase (CK) levels (P-value = 0.02). In older adults, after 12 wk, EMD appeared lower at all time points and RMS higher postexercise in the vitamin K2 group. No clear pattern in IL-6 or CK was observed, but at 72-h postexercise CK was lower in older adults in the vitamin K2 group. CONCLUSIONS: Vitamin K2 supplementation had no effect on muscle strength, physical function, muscle soreness, or inflammatory responses in the recovery period after a bout of resistance exercise. Effects of supplementation were observed on EMD, RMS, IL-6, and CK by age and warrant further investigation.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.